Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2206 AL 2220

Case of Sturge-Weber syndrome type III diagnosed during dementia examination

Kumagai R, Ichimiya Y.

Psychiatry Clin Neurosci. 2020 Dec;74(12):670-671. doi: 10.1111/pcn.13153. Epub 2020 Sep 28.

D-CARE: The Dementia Care Study: Design of a Pragmatic Trial of the Effectiveness and Cost Effectiveness of Health System-Based Versus Community-Based Dementia Care Versus Usual Dementia Care

Reuben DB, Gill TM, Stevens A, Williamson J, Volpi E, Lichtenstein M, Jennings LA, Tan Z, Evertson L, Bass D, Weitzman L, Carnie M, Wilson N, Araujo K, Charpentier P, Meng C, Greene EJ, Dziura J, Liu J, Unger E, Yang M, Currie K, Lenoir KM, Green AS, Abraham S, Vernon A, Samper-Ternent R, Raji M, Hirst RM, Galloway R, Finney GR, Ladd I, Rahm AK, Borek P, Peduzzi P.

J Am Geriatr Soc. 2020 Nov;68(11):2492-2499. doi: 10.1111/jgs.16862. Epub 2020 Oct 6.

[Spanish tools of cognitive and behavior assessment of alzheimer´s disease in severe state.]

Salmerón Ríos S, Lozoya Moreno S, Soler Moratalla I, Salmerón Ríos R, Ramírez Relinque L, Abizanda Soler P.

Rev Esp Salud Publica. 2020 Sep 21;94:e202009099.

Does APOE genotype moderate the relationship between physical activity, brain health and dementia risk? A systematic review

de Frutos-Lucas J, Frost N, Erickson KI, Serrano JM, Maestu F, Laws SM, Brown BM.

Ageing Res Rev. 2020 Dec;64:101173. doi: 10.1016/j.arr.2020.101173. Epub 2020 Sep 19.

The search for Alzheimer disease therapeutics - same targets, better trials?

Rafii MS, Aisen PS.

Nat Rev Neurol. 2020 Nov;16(11):597-598. doi: 10.1038/s41582-020-00414-3.

Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer's disease: an observational clinical study

Amin J, Boche D, Clough Z, Teeling J, Williams A, Gao Y, Chudley L, Lau L, Smith F, Harris S, Holmes C.

J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1219-1226. doi: 10.1136/jnnp-2020-323603. Epub 2020 Sep 23.

Amyloid PET imaging in clinical practice

Kolanko MA, Win Z, Loreto F, Patel N, Carswell C, Gontsarova A, Perry RJ, Malhotra PA.

Pract Neurol. 2020 Dec;20(6):451-462. doi: 10.1136/practneurol-2019-002468. Epub 2020 Sep 24.

Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias

Hanes J, Kovac A, Kvartsberg H, Kontsekova E, Fialova L, Katina S, Kovacech B, Stevens E, Hort J, Vyhnalek M, Boonkamp L, Novak M, Zetterberg H, Hansson O, Scheltens P, Blennow K, Teunissen CE, Zilka N.

Neurology. 2020 Dec 1;95(22):e3026-e3035. doi: 10.1212/WNL.0000000000010814. Epub 2020 Sep 24.

Examination of the Psychometric Properties of Marwit-Meuser Caregiver Grief Inventory-Short Form

Ar Karcı Y, Karancı AN.

Turk Psikiyatri Derg. 2020 Fall;31(3):192-200. doi: 10.5080/u23501.

Transitioning to Long-Term Care: Family Caregiver Experiences of Dementia, Communities, and Counseling

Zmora R, Statz TL, Birkeland RW, McCarron HR, Finlay JM, Rosebush CE, Gaugler JE.

J Aging Health. 2021 Jan;33(1-2):133-146. doi: 10.1177/0898264320963588. Epub 2020 Sep 29.

First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease

Barthel H.

J Nucl Med. 2020 Oct;61(10):1409-1410. doi: 10.2967/jnumed.120.252411.

Therapeutic Potential of TNF-α Inhibition for Alzheimer's Disease Prevention

Torres-Acosta N, O'Keefe JH, O'Keefe EL, Isaacson R, Small G.

J Alzheimers Dis. 2020;78(2):619-626. doi: 10.3233/JAD-200711.

Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil

Levine SZ, Yoshida K, Goldberg Y, Samara M, Cipriani A, Efthimiou O, Iwatsubo T, Leucht S, Furukawa TA.

Evid Based Ment Health. 2021 May;24(2):56-61. doi: 10.1136/ebmental-2020-300184. Epub 2020 Oct 6.

Evaluation of Discriminative Detection Abilities of Social Cognition Measures for the Diagnosis of the Behavioral Variant of Frontotemporal Dementia: a Systematic Review

Dodich A, Crespi C, Santi GC, Cappa SF, Cerami C.

Neuropsychol Rev. 2021 Jun;31(2):251-266. doi: 10.1007/s11065-020-09457-1. Epub 2020 Oct 10.

Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer's disease

Angrist M, Yang A, Kantor B, Chiba-Falek O.

Life Sci Soc Policy. 2020 Oct 12;16(1):11. doi: 10.1186/s40504-020-00106-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias